A recent in vitro study of plasma protein and distribution of Pt by Morris et al. [41] reported an increase in toxic CDDP-derived hydrolysis products and a decrease in protein bound Pt in the plasma of pediatric cancer patients with low serum albumin, when compared to plasma from healthy controls. The gene discussed is ALB; the disease is cancer.